BTI Q2 2026 Earnings Call Transcript
Thursday, July 30, 2026 at 4:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer - Tadeu Marroco Interim Chief Financial Officer - Javed Iqbal Group Head of Investor Relations - Victoria Buxton TAKEAWAYS Group Revenue -- 2.9% growth at constant currency, reflecting multi-category performance in the U.S. and an acceleration in New Category growth. Adjusted Diluted EPS -- 7.9% increase, supported by lower net finance costs following debt repayment and 4.4% growth from earning kickers.
How this was made
The 30-second read
Why it matters
Traders can update models using the upgraded full-year EPS range, expected lower net finance costs, margin expansion drivers, and the 2026 buyback allocation, while stress-testing heated-product weakness and APMEA regulatory risk.
Market read
The transcript includes multiple model-moving disclosures: upgraded EPS guidance, lower expected net finance costs, specified buyback funding, and quantified smokeless consumer and revenue growth.
What to watch
Fit2Win one-off costs and manufacturing asset upgrade charges could pressure future margins or cash conversion if savings delivery slips; also, U.S. vapour growth is partly tied to enforcement frameworks that could change.
Background
BTI’s call centers on its Fit2Win transformation, mix shift toward smokeless, and capital returns, with regional divergence between U.S. momentum and APMEA headwinds.
Ticker impact
British American Tobacco reported Q2 2026 transformation progress, including smokeless revenue share near 20% and upgraded full-year EPS guidance.
Moderate positive bias for the next few sessions as traders reprice EPS and buyback expectations, with volatility around any skepticism on heated-product declines and APMEA regulatory headwinds.
The article provides multiple decision-relevant datapoints: upgraded EPS range, lower expected net finance costs from debt repayment, and a specified 2026 buyback allocation, all tied to management’s transformation execution.
Market effects
Reinforces the U.S. smokeless and modern oral category read-through, potentially supporting sentiment for nicotine-pouch and vapour peers.
Highlights APMEA regulatory and illicit-volume drag, which may keep regional risk premia elevated for tobacco harm-reduction strategies.
Debt repayment and finance-cost guidance can influence broader capital-allocation expectations across large-cap tobacco.
Counterpoint
Heated product revenue is still declining and APMEA is down on regulatory and illicit volume, so the EPS upgrade may rely on execution and phasing rather than broad-based demand strength.
Key entities
- companyBritish American Tobacco p.l.c.
Subject of the earnings call transcript, providing smokeless mix metrics, margin and EPS guidance, and capital allocation details.
- executiveTadeu Marroco
CEO quoted on transformation momentum, U.S. vapour enforcement dynamics, and product launch timing (Velo Max).
- executiveJaved Iqbal
Interim CFO discussing financial performance drivers, including net finance cost outlook and Fit2Win savings.
